Bayer Links
Copyright ©
Bayer HealthCare AG
News archive
Bayer Schering Pharma Extends Research Portfolio in the Field of Cancer-Related Targets
License Agreement with Celera Corporation on five cancer target molecules » more
Duration matters!
Restoring longer love-making in men with erectile dysfunction » more
Bayer completes Phase II Study on BAY 94-9172 in Alzheimer’s Disease Imaging
Diagnostic Imaging Using Positron Emission Tomography (PET) » more
Discovering Europe on two wheels
Diabetic Paul Farelly finished his European Cycle Challenge from Portsmouth to Istanbul » more
European Journalists’ Prize goes to Volker Stollorz
Award sponsored by the Association of German Medical Journalists (VDMJ) and Bayer HealthCare AG » more
U.S. FDA Issues Complete Response Letter for Rivaroxaban
No new clinical or non-clinical studies to be conducted as a pre-requisite for approval » more
Bayer Schering Pharma To Present Data on Oncology Development Compound BAY 73-4506
45th Annual Meeting of the American Society of Clinical Oncology (ASCO) » more
Qlaira® – innovative estradiol-based oral contraceptive available in Europe from May onwards
A new oral contraceptive delivering the same estrogen as produced by the female body » more
“Corporate strategy proves effective in a difficult environment”
Earnings targets met in 2008 / Proposed 3.7 percent increase in dividend, to EUR 1.40 per share / CropScience and Pharmaceuticals remain on a path of growth in the current year / Group targets increasingly demanding following the slump in business at MaterialScience » more
“Corporate strategy proves effective in a difficult environment”
Address by Werner Wenning, Chairman of the Board of Management » more
Bayer presents new corporate image film
Premiere at the Annual Stockholders’ Meeting in Düsseldorf » more
Advances in Renal Cancer Journalists’ Award Europe goes to Malini Guha
Award sponsored by the Association of German Medical Journalists (VDMJ) and Bayer HealthCare AG » more
“With the right motivation, you can reach your goal”
Bayer Diabetes Care DreamFund™ winner cycles 2,000 miles across Europe » more
Bayer and Regeneron extend development program for VEGF Trap-Eye
Two phase III studies in Central Retinal Vein Occlusion (CRVO) to begin in the second half of this year » more
CropScience and Pharmaceuticals continue on a path of growth – Slump in business at MaterialScience leaves a distinct mark
Group sales: EUR 7,895 million (minus 7.5 percent) / EBITDA before special items: EUR 1,695 million (minus 22.4 percent) / EBIT before special items: EUR 1,017 million (minus 32.1 percent) / Net cash flow: EUR 693 million (plus 31.3 percent) » more
Phase III Trial of Nexavar® in Chemotherapy-Naive Patients with Advanced Melanoma Does Not Meet Primary Endpoint
Study stopped based on interim analysis » more
Blood glucose monitoring – the underrated key to successful therapy
Bayer HealthCare Diabetes Care helps simplify life for patients with diabetes and their health care providers » more
Pioneering diabetes management
Bayer HealthCare celebrates 40 years of innovative blood glucose monitoring » more
Not so delightful spring
Bepanthen eye and nasal ointment regenerates nasal mucosa and connective tissue / sea water nasal spray moistens and cares for noses plagued by allergies » more
Inadequate micronutrient status is more common than expected
Dietary supplements are key to maintaining health and well-being throughout life cycle » more
Search
Page tools
click to adjust font size
Social Bookmarks
Bayer HealthCare Links
Newsroom
